EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Association of the Glycated Albumin‐to‐Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort Analysis

Tomohito Gohda iD, Nozomu Kamei, Marenao Tanaka, Masato Furuhashi, Tatsuya Sato, Mitsunobu Kubota, Michiyoshi Sanuki, Risako Mikami, Koji Mizutani, Yusuke Suzuki, Maki Murakoshi

Endocrinology, Diabetes & Metabolism · 2025

DOI: 10.1002/edm2.70072 ↗

At a glance

Journal article in Endocrinology, Diabetes & Metabolism, 2025. Written by Tomohito Gohda and 10 co-authors. Institution: Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan. Major MEDLINE topics: Diabetes Mellitus, Type 2, Glycated Hemoglobin, Serum Albumin, Renal Insufficiency, Chronic. Cited 2 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

The glycated albumin‐to‐glycated haemoglobin (GA/HbA1c) ratio is a potential marker of glycaemic variability; however, its association with adverse clinical outcomes in type 2 diabetes remains unclear. We aimed to determine whether the GA/HbA1c ratio is a better predictor of mortality and chronic kidney disease (CKD) progression than GA alone in type 2 diabetes.

Methods

This retrospective cohort analysis included 571 Japanese participants with type 2 diabetes who were stratified into tertiles based on their GA/HbA1c ratio. Cox proportional hazards models assessed associations between the GA/HbA1c ratio and mortality or CKD progression (≥ 30% decline in the estimated glomerular filtration rate [eGFR]), adjusting for age, sex, urinary albumin‐to‐creatinine ratio, eGFR, body mass index, haemoglobin and serum albumin.

Results

In this cohort, the median age was 67 years, and 53.9% were male. During the median follow‐up of 5.4 and 5.3 years for mortality and CKD progression, respectively, 40 (7.0%) participants died and 70 (12.3%) experienced CKD progression. For mortality, the GA/HbA1c ratio demonstrated a U‐shaped association: although both the lowest (T1) and highest (T3) tertiles showed higher mortality risks than the middle tertile (T2), this association was significant for only T3 (hazard ratio, 1.46; 95% CI, 1.05–2.04). Neither GA nor HbA1c alone was significantly associated with mortality. For CKD progression, GA alone showed a U‐shaped association, with both T1 and T3 exhibiting non‐significantly higher risks than T2. Neither the GA/HbA1c ratio nor HbA1c alone was associated with CKD progression.

Conclusions

In individuals with type 2 diabetes, a higher GA/HbA1c ratio was associated with an increased risk of mortality but not with CKD progression. However, given the retrospective design and limited sample size, these findings should be interpreted with caution and confirmed in larger, prospective studies.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Glycated HemoglobinSerum AlbuminRenal Insufficiency, ChronicDiabetic NephropathiesHumansMaleFemaleRetrospective StudiesAgedGlycated Serum AlbuminMiddle AgedGlycation End Products, AdvancedDisease ProgressionBiomarkersGlomerular Filtration Rate

Author keywords

chronic kidney diseaseglycated haemoglobin‐to‐glycated albumin ratiomortalitytype 2 diabetes

Substances

Glycated HemoglobinSerum AlbuminGlycated Serum AlbuminGlycation End Products, Advancedhemoglobin A1c protein, humanBiomarkers

Authors and institutions

  • Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Institute for Clinical Research, NHO Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
  • Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Endocrinology and Diabetology, NHO Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.

ORCID profiles: Tomohito Gohda

Cite

APA

Gohda, T., Kamei, N., Tanaka, M., Furuhashi, M., Sato, T., Kubota, M., Sanuki, M., Mikami, R., Mizutani, K., Suzuki, Y., & Murakoshi, M. (2025). Association of the Glycated Albumin‐to‐Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort Analysis. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70072

Vancouver

Gohda T, Kamei N, Tanaka M, Furuhashi M, Sato T, Kubota M, et al. Association of the Glycated Albumin‐to‐Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort Analysis. Endocrinology, Diabetes & Metabolism. 2025. doi:10.1002/edm2.70072

BibTeX
@article{Gohda2025,
  author = {Gohda, Tomohito and Kamei, Nozomu and Tanaka, Marenao and Furuhashi, Masato and Sato, Tatsuya and Kubota, Mitsunobu and Sanuki, Michiyoshi and Mikami, Risako and Mizutani, Koji and Suzuki, Yusuke and Murakoshi, Maki},
  title = {Association of the Glycated Albumin‐to‐Glycated Haemoglobin Ratio With Mortality in Type 2 Diabetes: A Retrospective Cohort Analysis},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2025},
  doi = {10.1002/edm2.70072}
}
Start for free →